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Abstract
Background: Nucleolin is one of the major proteins of the nucleolus, but it is also expressed on the cell surface where is
serves as a binding protein for variety of ligands implicated in tumorigenesis and angiogenesis. Emerging evidence suggests
that the cell-surface expressed nucleolin is a strategic target for an effective and nontoxic cancer therapy.
Methodology/Principal Findings: By monitoring the expression of nucleolin mRNA, and by measuring the level of nucleolin
protein recovered from the surface and nucleus of cells, here we show that the presence of nucleolin at the cell surface is
dependent on the constant induction of nucleolin mRNA. Indeed, inhibitors of RNA transcription or translation block
expression of surface nucleolin while no apparent effect is observed on the level of nucleolin in the nucleus. The estimated
half-life of surface nucleolin is less than one hour, whereas that of nuclear nucleolin is more than 8 hours. Nucleolin mRNA
induction is reduced markedly in normal fibroblasts that reach confluence, while it occurs continuously even in post-
confluent epithelial tumor cells consistent with their capacity to proliferate without contact inhibition. Interestingly, cold
and heat shock induce nucleolin mRNA concomitantly to enhanced mRNA expression of the heat shock protein 70, thus
suggesting that surface nucleolin induction also occurs in response to an environmental insult. At the cell surface, one of
the main functions of nucleolin is to shuttle specific extracellular ligands by an active transport mechanism, which we show
here to be calcium dependent.
Conclusion/Significance: Our results demonstrate that the expression of surface nucleolin is an early metabolic event
coupled with tumor cell proliferation and stress response. The fact that surface nucleolin is constantly and abundantly
expressed on the surface of tumor cells, makes them a preferential target for the inhibitory action of anticancer agents that
target surface nucleolin.
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Introduction
Nucleolin is a multifunctional RNA- and protein-binding
protein ubiquitously expressed in exponentially growing eukary-
otic cells. It is involved in fundamental aspects of transcription, cell
proliferation and growth [1,2]. Nucleolin is found at several
locations in cells: in the nucleolus it controls many aspects of DNA
and RNA metabolism [3]; in the cytoplasm it shuttles proteins into
the nucleus and provides a post-transcriptional regulation of
strategic mRNAs [4,5]; and on the cell surface where it serves as
an attachment protein for several ligands from growth factors to
microorganisms [6,7,8,9,10,11,12]. Surface and cytoplasmic
nucleolin are differentiated from nuclear nucleolin by a slight
shift in their isoelectric point, probably as a consequence of specific
co- and/or post-translational modifications that determine routing
of the newly synthesized nucleolin to the nucleus or the plasma
membrane [6]. Moreover, surface and cytoplasmic nucleolin
appear to be down regulated independently of nuclear nucleolin,
since under some experimental conditions marked reduction of
surface/cytoplasmic nucleolin occurs without any apparent effect
on the level or nucleolar localization of nuclear nucleolin [13].
Both nuclear and surface nucleolin are phosphorylated; nuclear
nucleolin is phosphorylated by casein kinase 2 (CKII) at interphase
and by cell-cycle control CDC2 kinase during mitosis, whereas
surface nucleolin is phosphorylated by casein kinase-like ecto-
protein kinase [1,2].
In spite of the fact that nucleolin does not have a hydrophobic
transmembrane domain for anchorage in the plasma membrane,
cross-linking of surface nucleolin with a specific monoclonal
antibody results in its clustering in the plasma membrane. This
clustering occurs at the external side of the plasma membrane and
is dependent on its association with the intracellular actin
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myosin heavy chain 9, could serve as a physical linker between
surface nucleolin and actin [14]. Upon stimulation of cell
proliferation, cytoplasmic nucleolin is translocated via small
vesicles to the surface through a temperature-dependent but
unconventional secretory pathway, since such an active translo-
cation is not affected by inhibitors of the classical pathway for
secretion through the endoplasmic reticulum and Golgi apparatus
[6]. Interestingly, N-linked glycosylation of cytoplasmic nucleolin
appears to be an essential requirement for the expression of
nucleolin on the surface of different types of cells [15]. Surface
nucleolin serves as a low affinity receptor for HIV-1 and various
growth factors that interact with its C-terminal domain containing
nine repeats of the tripeptide arginine-glycine-glycine, known as
the RGG or GAR domain [10,16,17,18,19]. Binding of these
ligands results in clustering of cell-surface nucleolin in lipid raft
membrane microdomains before endocytosis of the ligand-
nucleolin complex [10,17,19]. Accordingly, surface nucleolin
could shuttle ligands between the cell surface and the nucleus
thus act as a mediator for the extracellular regulation of nuclear
events [18,20,21].
Interestingly, most of ligands of surface nucleolin play a critical
rolein tumorigenesis and angiogenesis.Forexample,among surface
nucleolin binding growth factors and proteins, midkine and
pleiotrophin can transform cells, whereas on endothelial cells they
exert both mitogenic and angiogenic effect [22,23]. Urokinase that
also binds the RGG domain of nucleolin is implicated in
mechanisms regulating pericellular proteolysis, cell-surface adhe-
sion, and mitogenesis [21,24]. Other surface nucleolin binding
proteins such as laminin-1, factor J, L- and P-selectins, and
hepatocyte growth factor that are involved in tumor development,
induce cell differentiation, regulate cell adhesion, leukocyte
trafficking, inflammation, and angiogenesis [25,26,27,28,29,30].
The tumor homing peptide F3 that binds both endothelial and
tumor cells is internalized via surface nucleolin, while endostatin
that inhibits angiogenesis binds nucleolin on the surface of
endothelial cells before translocation to the nucleus [31,32]. Con-
sequently, the functional blockade or down regulation of surface
nucleolin in endothelial cells inhibits migration of endothelial cells
and prevents capillary-tubule formation [13,14].
Following interaction with various ligands, surface nucleolin
might be implicated directly or indirectly in signal transduction
events [33]. For example, surface nucleolin has been shown to serve
the binding partner for receptor protein tyrosine phosphatase-
sigma ectodomain in skeletal muscle [34], whereas the interaction
of surface nucleolin with ErbB receptor tyrosine kinases induces
receptor dimerization, phosphorylation and to anchorage inde-
pendent growth [35]. The binding of P-selectin to human colon
carcinoma cells is shown to induce tyrosine phosphorylation of
surface nucleolin and formation of a signaling complex containing
nucleolin, phosphatidylinositol 3-kinase (PI3-K) and p38 MAPK
[29]. Finally, ligand binding to surface nucleolin could generate
high transitory intracellular Ca
2+ membrane fluxes involving SOC-
like channels, and thus initiate signaling events [15]. Consistent
with this, plasma membrane localized nucleolin with nucleophos-
min interact with K-Ras and play a critical role in signal
transduction via the MAPK pathway [36].
These various reports on the implication of surface nucleolin in
growthoftumorcellsandangiogenesishighlightsurface nucleolinas
a promising target for cancer therapy. Accordingly, we recently
reported that the progression ofestablished humanbreasttumorcell
xenografts in the nude mice is suppressed by targeting surface
nucleolin with a specific antagonist, the HB-19 pseudopeptide, that
binds the RGG domain of nucleolin [13,16]. HB-19 prevents
binding of growth factors to cells, triggers calcium entry into cells,
inhibits MAP kinase activation, and down regulates surface
nucleolin without affecting nuclear nucleolin [7,9,13,15,16,18,19].
In a more relevant tumor model, we showed that HB-19 treatment
for several months delays significantly the onset and frequency of
spontaneous melanoma in RET mice, and reduces visceral
metastatic nodules while displaying no toxicity to normal tissue
[37,38]. Studies on the melanoma-derived tumor cells demonstrat-
ed that HB-19 treatment could restore contact inhibition, impair
anchorage-independent growth, and inhibit expression of specific
genes implicated in tumorigenesis [37]. Previously, guanosine-rich
quadruplex-forming oligodeoxynucleotides (GROs) that interact
with surface nucleolin and/or intracellular nucleolin have been
shown to be promising agents for treatment of cancer [39,40,41].
The aptamer AS1411 is the most recent GRO that is currently
being tested in Phase II clinical trials. The proposed model for
AS1411 mechanism of action involves inhibition of molecular
interactions between nucleolin and its binding partners, such as NF-
kB essential modulator (NEMO also known as IKKc), arginine
methyltransferase 5 (RPMT5) and the instability AU-rich element
of bcl-2 mRNA [42,43,44].
In this study, we provide evidence to show for the first time that
surface nucleolin is a de novo synthesized protein constantly induced
in tumor and endothelial cells. Accordingly, inhibitors of RNA
transcription or translation block the expression of surface
nucleolin in the absence of any apparent effect on nuclear
nucleolin. The estimated half-life of surface nucleolin is about 45
minutes whereas that of nuclear nucleolin is more than 8 hours. At
the cell surface, nucleolin mediates internalization of specific
ligands in a calcium-dependent manner. Consequently, chelating
divalent calcium from the culture medium blocks ligand and
surface nucleolin internalization. Finally, the observation that the
level of nucleolin mRNA is reduced by inhibition of mRNA
transcription but not by mRNA translation is consistent with an
induction mechanism that is a primary induction process not
requiring the synthesis of other proteins. Taken together, our
results demonstrate that the induction and down regulation of
surface nucleolin is associated with the proliferative capacity of
cells, and occur independently of nuclear nucleolin. This latter
could account, at least in part, for the lack of toxicity observed
during the prolonged treatment of tumor bearing mice with HB-
19 [13,37]. The differential expression and specific functions of
surface and nuclear nucleolin indicate the need to distinguish
between these two forms of nucleolin in future studies in order to
avoid possible misinterpretations of experimental data.
Results
Surface nucleolin can be isolated conveniently by the capacity of
HB-19 to form a stable and an irreversible complex with it [9].
Consequently, incubation of cells with biotinylated HB-19 and
followed by purification of cell extracts using avidin-agarose
provide an efficient method for monitoring surface nucleolin
expression. In different types of cells, HB-19 binds surface
nucleolin in a dose-dependent manner with maximum binding
occurring at 1–5 mM concentration [12,13,15,45]. In this study,
measuring the level of surface nucleolin separately of nuclear
nucleolin was the key step to demonstrate that surface nucleolin is
a continuously induced protein in different types of tumor cells.
Surface nucleolin is constantly induced in cells
Our previous studies by laser scanning confocal immunofluo-
rescence microscopy have suggested that transcriptional and
translational events are implicated for the expression of nucleolin
Expression of Surface-Nucleolin in Tumor Cells
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expression of nucleolin mRNA in MDA-MB-231 cells along with
the level of nucleolin protein at the cell surface, in the nucleus and
in the nuclear-free subcellular fraction that contains both
cytoplasmic and plasma membrane proteins (referred to as
cytoplasmic fraction). We first showed that nucleolin mRNA is
constantly induced in subconfluent and confluent MDA-MB-231
cells, since inhibiting transcription with actinomycin D decreases
nucleolin mRNA by more than 85% (Fig. 1A). We next
investigated the expression of nucleolin mRNA and protein in
confluent cells in response to inhibitors of transcription, transla-
tion, and N-glycosylation (Fig. 1B and 1C). Consistent with the
results in Fig. 1A, actinomycin D prevented markedly nucleolin
mRNA expression, while the protein synthesis inhibitor cyclohex-
imide had no apparent effect, thus suggesting that nucleolin
mRNA induction is a direct induction process not requiring newly
synthesized proteins. Furthermore, the induction of nucleolin
mRNA is a specific event since it occurs in the absence of any
apparent effect on the relative amounts of the house-keeping
GAPDH mRNA (Fig. 1A and 1B).
As for the nucleolin protein expression, the reduced levels of
nucleolin mRNA in actinomycin D treated cells is accompanied by
marked reduction of surface and cytoplasmic but not nuclear
nucleolin, thus indicating that the expression of surface/cytoplas-
mic nucleolin is dependent on the constant induction of nucleolin
mRNA. Consistent with this, translation of the induced nucleolin
mRNA is necessary for the expression of both cytoplasmic and
surface nucleolin, since cycloheximide treatment of cells causes
a specific decline of cytoplasmic/surface nucleolin without an
apparent effect on nucleolin mRNA (Fig. 1B and 1C). We have
recently reported that N-linked glycosylation is an essential
requirement for the expression of nucleolin at the cell surface
[15]. Interestingly, N-glycosylation inhibitor tunicamycin has no
apparent effect on the induction of nucleolin mRNA, which is
translated to generate cytoplasmic but not surface nucleolin
(Fig. 1B and 1C). Therefore nucleolin is synthesized in the
presence of tunicamycin but its translocation to the cell surface is
prevented because it is not glycosylated. It should be noted that the
level of nucleolin in the nucleus remains constant in cells treated
with actinomycin D, cycloheximide or tunicamycin that cause a
marked reduction of surface nucleolin, thus indicating that these
inhibitors exert a specific effect on the expression of surface
nucleolin (Fig. 1C). Accordingly, confocal laser immunofluores-
cence microscopy studies have indicated that nuclear nucleolin
does not translocate to the cytoplasm when surface nucleolin levels
are reduced in the presence of the transcription and translation
inhibitors [6]. Nevertheless, It is noteworthy to mention that in the
presence of actinomycin D or cycloheximide, nucleolin becomes
re-distributed from the nucleolus into the nucleoplasm (Data not
shown).
The half-life of nucleolin mRNA monitored by RT-PCR (not
shown) or by RT-Q-PCR (Fig. 2A) is estimated to be about 90
minutes. The half-life of the nucleolin protein monitored by
immunoblotting of crude nuclear-free subcellular fractions and the
purified surface nucleolin is estimated to be about 45 minutes and
less than one hour, respectively (Fig. 2B and 2C). On the other
hand, no apparent effect is observed on the level of nuclear
nucleolin in cycloheximide treated cells for 8 hours, when there is
almost complete disappearance of cytoplasmic/surface nucleolin
(Figure 2D). These observations suggest that surface/cytoplasmic
nucleolin represents the majority of the newly synthesized protein
detectable at a given time, the proportion of which in different
types of cells is less than 10% of nucleolin located in the nucleus
[6,46]. Consequently, our results do not exclude the potential
translocation of some of the newly synthesized nucleolin to the
nucleus, since a slight increase would not modify significantly the
overall level of nuclear nucleolin. Whatever is the case, the absence
of an apparent effect on nuclear nucleolin after 8 hours of
cycloheximide treatment indicates clearly that nuclear nucleolin
has a prolonged half-life. In accord with this, other workers have
reported that a drop or rise of nucleolin mRNA have no apparent
effect on the level of nucleolin protein as measured in total cell
extracts [47]. Therefore, the differential expression of cytoplas-
mic/surface nucleolin in respect to nuclear nucleolin is character-
ized by constant induction and the short half-life of cytoplasmic/
surface nucleolin.
Consistent with the results observed in the human breast
carcinoma cells (MDA-MB-231, MDA-MB-435), the constant
induction of nucleolin mRNA is also observed in the human
carcinoma (LNCaP, HeLa, G401) and leukemia (Jurkat, HuT 78,
CEM) cell lines that were investigated. In these cells, the steady
state levels of nucleolin mRNA were reduced by 69–93% in
response to treatment with actinomycin D during a period of
four hours (Fig. 3). Among the different types of cancer cells, the
Figure 1. Induction of surface nucleolin expression in the
human breast cancer cell line, MDA-MB-231. The expression of
nucleolin (NCL) and GAPDH mRNA (Panels A and B: by RT-PCR) and
nucleolin protein (Panel C: by immunoblotting of cell extracts) were
monitored in MDA-MB-231 cells cultured in the absence (lane - or C) or
in the presence of 5 mg/ml actinomycin D (lanes Act. D) or 50 mg/ml
cycloheximide (lanes CHX) or 10 mg/ml tunicamycin (lanes TM) for
5 hours. A. Constitutive induction of nucleolin mRNA in proliferating
MDA-MB-231 cells without (lanes -) or with (lanes +) actinomycin D
treatment at days 2 and 4 after passage, respectively (lanes D2 and
lanes D4). B. Expression of nucleolin mRNA level in serum-stimulated
subconfluent cells in the absence (lane C) or presence of actinomycin D,
cycloheximide, and tunicamycin. C. Nucleolin expression at the cell
surface (panel Surface), in cytoplasmic (containing both surface and
cytoplasmic proteins) and nuclear extracts. MDA-MB-231 cells cultured
for 5 hours with various inhibitors were further incubated (20uC,
45 min) with 5 mM HB-19/Btn in order to monitor the cell surface
expressed nucleolin. Samples of the purified surface nucleolin (material
from 5610
6 cells) and crude cytoplasmic and nuclear extracts (material
from 2610
6 cells) were analyzed by immunoblotting using anti-
nucleolin monoclonal antibody D3. The size of RT-PCR product for
nucleolin and GAPDH was 835 and 983 bp, respectively. Note. The
stained PAGE-SDS gel showed no apparent differences in cytoplasmic
extracts that were obtained from cells treated with various inhibitors
compared to the control sample.
doi:10.1371/journal.pone.0015787.g001
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the epithelial tumor cells, which is in accord with a recent report
showing that nucleolin is over expressed in acute myelogenous
leukemia cells [48].
Down regulation of surface nucleolin in HB-19 treated
cells does not affect induction of nucleolin mRNA
Treatment of cells with HB-19, the nucleolin antagonist-
pseudopeptide, results in a dose dependent reduction of surface/
cytoplasmic nucleolin without any apparent effect on nuclear
nucleolin (Fig. 4A–B), or on the expression of other cytoplasmic
proteins (data not shown). Therefore, the marked drop of
cytoplasmic/surface nucleolin in HB-19 treated cells is a specific
and a selective effect. In spite of this, no apparent effect is observed
on the level of nucleolin RNA in HB-19 treated cells (Fig. 4C),
even after 24–48 hours of treatment when cytoplasmic nucleolin
becomes no longer detectable [13]. Consistently, the steady state
levels of nucleolin mRNA was found to be slightly higher in HB-19
treated compared to untreated cells; an effect that might reflect
enhanced stability of nucleolin mRNA as a consequence of the
translational block, as it is the case with the translational inhibitor
cycloheximide (Fig. 4C, histogram CHX). Accordingly, the
estimated half-life of nucleolin mRNA in HB-19 treated cells, as
monitored in the presence of actinomycin D, is slightly higher
compared to untreated cells (Fig. 4D).
The expression of nucleolin on the surface of endothelial
cells is due to the induction of nucleolin mRNA
The expression of nucleolin on the surface of human umbilical
vein endothelial cells (HUVECs) was recently suggested to be the
consequence of translocation of nucleolar nucleolin to the surface
when HUVECs are activated by vascular endothelial growth
factor (VEGF) [14]. Like other cell types however, we show here
that surface nucleolin expression is associated with induction of
nucleolin mRNA in activated HUVECs. Indeed, expression of
nucleolin on the surface of HUVECs as well as nucleolin mRNA
are markedly reduced in cultures incubated with actinomycin D
for few hours (Fig. 5A–B, lanes 1–2; Fig. 5C). Nucleolin mRNA is
also reduced in HUVECs starved for 24 hours, but addition of
complete culture medium rapidly restores nucleolin mRNA levels
(Fig. 5A–B, lanes 3–4). Interestingly, addition of VEGF is also
sufficient to induce nucleolin mRNA levels in starved HUVECs
(Fig. 5, lanes 5–6), thus indicating that induction of nucleolin
mRNA is one of the early events in endothelial cells in response to
activation by VEGF.
The constant induction of nucleolin mRNA is associated
with the proliferative capacity of tumor cells
The growth of normal cells is arrested due to contact inhibition
with the increase in cell density, whereas tumor cells proliferate
even at post-confluent densities. In view of these, we investigated
the induction of nucleolin mRNA in subconfluent, confluent, and
post-confluent tumor cells and compared to that observed in
normal 3T3 cells, which stop proliferation once they have reached
confluence (Fig. 6A). At different times after cell passage, we
confirmed that the presence of nucleolin mRNA is due to an
induction process as demonstrated by a marked reduction in the
presence of actinomycin D (not presented). In breast and prostate
carcinoma cells (MDA-MB-231, MDA-MB-435, LNCaP), nucleo-
lin mRNA was induced constantly, and even there was a slight
increase at post-confluence in the breast cancer cell lines MDA-
MB-231 and MDA-MB-435 (Fig. 6A). In 3T3 cells however,
nucleolin mRNA induction was reduced 40 and 60% at day 2 and
3 of cell passage that correspond to subconfluent and confluent
cells, respectively (Fig. 6A). These results suggest that the induction
of surface nucleolin is linked to the proliferative capacity of both
normal and tumor cells. In normal cells the induction is down
regulated one day after cell passage, whereas in tumor cells the
Figure 2. Half-life of nucleolin mRNA and the cytoplasmic and
surface nucleolin. A. Half life nucleolin mRNA. MDA-MB-231 cells in
the presence of 5 mg/ml actinomycin were cultured for 30, 60, 120 and
180 min before extraction of cells. Time 0 represents the control
sample. Nucleolin mRNA expression was analyzed by Q-PCR using
GAPDH RNA as endogenous control RNA (Materials and methods). B.
Half-life of cytoplasmic/surface nucleolin protein. MDA-MB-231 cells
were cultured in the presence of 50 mg/ml of cycloheximide for 30, 60,
90 and 120 min. Nucleolin protein was monitored by immunoblotting
of crude cytoplasmic cell extracts. A section of the gel is shown. The
intensity of nucleolin protein bands was quantified by using the NIH
image software. C. Half-life of the cell-surface expressed nucleolin.
MDA-MB-231 and MDA-MB-435 cells were cultured for 1, 2 and 4 hours.
At time 0 or 1, 2 and 4 hours of treatment with cycloheximide (50 mg/
ml), cells were transferred to room temperature for the recovery of
surface nucleolin using HB-19/Btn. Sections of the immunoblot at the
position of nucleolin are presented. D. Nucleolar nucleolin is a highly
stable protein compared to its cytoplasmic/surface counterpart. MDA-
MB-435 cells cultured in the presence of cycloheximide for 0, 2, 4, and
8 hours were analyzed by immunoblotting for nucleolin expression in
crude cytoplasmic and nuclear extracts containing cytoplasmic/surface
(panel Surface/Cyt. NCL) and nuclear (panel Nuclear NCL) nucleolin.
doi:10.1371/journal.pone.0015787.g002
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conditions to proliferate. Indeed, when tumor cell metabolism was
slowed down by incubation at 20uC for 4 hours, then there was 91
and 80% reduction of nucleolin mRNA in MDA-MB-231 and
MDA-MB-435 cells respectively (Fig. 6B).
Rapid induction of nucleolin mRNA after a cold or heat
shock
Analysis of nucleolin mRNA expression at low temperatures,
revealed that the steady levels of nucleolin mRNA are increased
consistently and concomitantly with that of the stress-induced heat
shock protein Hsp70. For example, 15 min at 4uC followed by one
hour incubation at room temperature (20uC) leads to enhanced
expression of nucleolin and Hsp70 mRNA in MDA-MB-435 cells,
whereas no apparent effect is observed on another nucleolar
protein, nucleophosmin (Fig. 7A, lanes 0 and 1). Interestingly, a
strong reduction of nucleolin mRNA is observed at 2 hours after
the cold shock, which is in accord with the short half-life of surface
nucleolin mRNA (Fig. 7A, lane 2). Two major cold-inducible
RNA-binding proteins are described in human cells, CIRP (also
known as A18 hnRNP) and RBM3 (for RNA binding motif
protein 3) [49]. However, no apparent effect is observed on the
expression of CIRP and RBM3 after 1–2 hours of the cold shock
(Fig. 7A). The enhanced steady state levels of nucleolin and Hsp70
mRNA is due to a specific induction event, since they are
markedly reduced with actinomycin D treatment, which has no
apparent effect on the expression of nucleophosmin, CIRP,
RBM3, and GAPDH (Fig. 7B).
Similarly, nucleolin mRNA is selectively induced following a
heat shock stress at 44uC, an event that occurs concomitantly with
a strong induction of the Hsp70 mRNA (Fig. 7C). By RT-Q-PCR
analysis we further confirmed the induction of nucleolin and
Hsp70 mRNA after a cold and heat shock treatment in MDA-MB-
435 (Fig. 7D and 7E) and HeLa (Data not presented) cells.
Overall, these studies demonstrated that cold shock at 4uCi sa
better inducer of nucleolin mRNA compared to heat shock,
whereas heat shock is a better inducer of Hsp70 mRNA compared
to cold shock. Thus, enhanced expression of nucleolin appears to
be one of the immediate responses of cells to an environmental
insult. Finally, it is of interest to note that 15 minutes heat but not
cold shock affects directly the stability of nucleolin mRNA with
more than 50% reduction (Fig. 7D, histograms 0 Hour/4uC and
0 Hour/44uC) compared to the level observed before the shock
(Fig. 7D, histogram C).
Cell surface nucleolin mediates calcium dependent
internalization of ligands
HIV-1 particles and physiological ligands that bind the RGG
domain of nucleolin (Midkine, pleiotrophin, lactoferrin) induce
aggregation of surface nucleolin, before internalization into
various cell types by an active process via lipid raft microdomains
[7,10,17,18,19]. Here we used two specific ligands to illustrate
calcium dependent internalization into HeLa cells through surface
nucleolin: the nucleolin antagonist HB-19 pseudopeptide that
binds the RGG domain, and the nucleolin specific monoclonal
antibody D3 that binds the second RNA binding domain RBD2
[6,9] (A.G.H. unpublished data). Like the physiological ligands of
surface nucleolin, HB-19 and mAb D3 are internalized at 37uC
but not or very little at reduced temperatures, thus further
confirming that internalization via surface nucleolin occurs by an
active process [6,9]. It should be noted that internalization via
surface nucleolin is a specific event, since under similar
experimental conditions the basic amino acid-rich Tat peptide
translocates rapidly through the plasma membrane to the nuclei
and is accumulated into the nucleoli of cells as reported previously
(data not presented, as in reference [50]).
During studies on entry of various ligands into different types of
cells, we noticed that entry is more pronounced in cells cultured in
DMEM compared to RPMI-1640 medium, in which the
concentration of calcium is 1.8 and 0.42 mM, respectively. An
example is presented for the entry of HB-19 into HeLa cells that
were incubated at 37uC for 90 minutes in fresh culture medium
using either DMEM or RPMI (Fig. 8A and 8C). This difference in
the level of HB-19 internalization is due to the difference in the
concentration of calcium, since entry is markedly reduced in
DMEM-cultured cells in the presence of the extracellular calcium
chelator EGTA, and inversely entry is strongly enhanced in
RPMI-cultured cells supplemented with 2 mM CaCl2 (Fig. 8B and
8D). Similar results were observed for the internalization of
midkine into DMEM-cultured cells [17] where entry is more
pronounced in the presence of additional CaCl2, while EGTA
reduces markedly the entry process (data not shown).
It should be noted that in different types of cells, the cytoplasmic
nucleolin signal observed by confocal immunofluorescence
Figure 3. Relative expression of nucleolin mRNA in various human cell lines. Subconfluent adherent cells (MDA-MB-231, MDA-MB-435,
LNCaP, HeLa, G401) and cells in suspension at 5610
5 cells/ml (Jurkat, HuT 78, CEM) were cultured in the absence or presence of 5 mg/ml actinomycin.
After 4 hours, extracts were prepared and analyzed for nucleolin mRNA by Q-PCR using 28S ribosomal RNA as endogenous control RNA as described
in the Materials and methods. For comparative purposes, the level of nucleolin expression in the absence of actinomycin D in MDA-MB-321 cells was
considered 100%. The percent inhibition of nucleolin mRNA expression in the presence of actinomycin D is given individually for each cell type.
doi:10.1371/journal.pone.0015787.g003
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elevated intensity. However following ligand entry, the signal in
the cytoplasm is increased and is detectable at the experimental
intensity due to the internalization of the ligand-surface nucleolin
complex. In order to follow the influence of calcium concentration
on the translocation of surface nucleolin during the ligand entry
process, we used mAb D3 that forms Triton-insoluble aggregates
with surface nucleolin and is internalized at 37uC. For this
purpose, cells preincubated with mAb D3 in the absence or
presence of EGTA or additional CaCl2 were fixed with PFA to
evaluate the amount of nucleolin present on the cell surface, or
fixed with PFA-Triton to monitor internalization of surface
nucleolin (Fig. 9). In control cells, considerable amount of
nucleolin was present on the surface of control cells as well as in
the cytoplasm (Fig. 9A, 9D). In the presence of the additional
CaCl2, surface nucleolin internalization was strongly enhanced
with concomitant reduction of surface nucleolin (Fig. 9B, 9E).
Finally, chelating CaCl2 with EGTA prevented surface nucleolin
internalization while at the same time it increased the surface
nucleolin signal at the plasma membrane (Fig. 9C, 9F). The
persistence of clustered surface nucleolin in such PFA-Triton fixed
cells in the presence of EGTA indicates that chelation of CaCl2
does not affect translocation of the newly synthesized nucleolin
towards the plasma membrane, but since internalization is blocked
then nucleolin becomes accumulated in the plasma membrane
probably in triton insoluble microdomains. Taken together, our
data demonstrate that calcium plays an important role in the
internalization process of ligands via surface nucleolin.
Discussion
By monitoring the expression of nucleolin mRNA and by
measuring separately the level of surface, cytoplasmic and nuclear
nucleolin protein, we demonstrate here that nucleolin mRNA is
constantly induced in tumor cells to synthesize nucleolin that is
rapidly translocated to the cell surface. The estimated half-life of
nucleolin mRNA and cytoplasmic/surface nucleolin is about 90
and 45 minutes, respectively, whereas the half-life of nuclear
nucleolin could be more than 24 hours as reported before [47].
Surface/cytoplasmic nucleolin therefore is differentially expressed
compared to its nuclear counterpart. Consistent with this, the
reduced levels of nucleolin mRNA in response to inhibition of
RNA transcription is accompanied by marked reduction of surface
and cytoplasmic but not nuclear nucleolin. Others have reported
that surface nucleolin is the product of nuclear nucleolin trans-
location to the cell surface by comparing enhanced levels of
surface nucleolin or nucleolin mRNA with the level of nucleolin
protein in total cell lysates, i.e., mixture of nuclear, cytoplasmic
and surface nucleolin [14,47]. The proportion of the steady state
levels of surface nucleolin in different types of cell is 5–10% of
nucleolin found in total cell extracts [6,46]. Consequently, the
measurement of total cellular nucleolin protein cannot be used as
an indication of the changes in surface nucleolin, since they can
lead to inaccurate interpretation of the relationship between
nuclear and cell-surface presence of nucleolin. The constant
induction of surface nucleolin under various growth and stress
Figure 4. HB-19 down regulates expression of surface nucleolin
without affecting the induction of nucleolin mRNA. A–B. Specific
reduction of surface but not nuclear nucleolin in HB-19 treated cells.
MDA-MB-231 cells were cultured with HB-19 at 0, 1, 2.5, 5 and 10 mMo f
for 5 hours before preparation of cytoplasmic (i.e, containing cytoplas-
mic and plasma membrane proteins) and nuclear extracts. Material from
2610
6 cells was analyzed by immunoblotting for the detection of
nucleolin. Sections at the position of nucleolin are presented. PAGE-SDS
gels containing similar samples were stained with Brilliant Blue G-
Colloidal Concentrate in order to monitor the protein profile in the
crude cell extracts (not presented). C. Nucleolin mRNA level is not
affected in HB-19 treated cells. MDA-MB-231 cells in the absence
(control) or presence of actinomycin D (5 mg/ml), cycloheximide (50 mg/
ml), and HB-19 (5, 10, 20 mM) were cultured for 5 hours before analysis
of nucleolin mRNA expression by Q-PCR using GAPDH RNA as
endogenous control RNA. The expression of nucleolin mRNA in the
control sample was considered as 100%. D. The half-life of nucleolin
mRNA in HB-19 treated cells is delayed slightly compared to untreated
cells. MDA-MB-231 cells in the absence (control) or presence of 10 mM
HB-19 were cultured for 24 hours before addition of actinomycin D
(5 mg/ml). After 1, 2, and 3 hours, nucleolin mRNA expression was
carried out by Q-PCR using GAPDH RNA as endogenous control mRNA.
The percent inhibition of nucleolin mRNA expression given above the
histograms was calculated in comparison with the control or HB-19
treated sample at 0 hour.
doi:10.1371/journal.pone.0015787.g004
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nuclear nucleolin should take into consideration the potential
contribution of surface nucleolin, in order to provide a more
comprehensive analysis of experimental observations.
Since the first report of surface expression of nucleolin in
hepatocarcinoma cells [51], emerging evidences suggest that cell-
surface nucleolin is implicated in cell proliferation, tumor cell
growth and angiogenesis. The enhanced expression of surface
nucleolin is observed in vitro and in vivo in lymphoid organs
containing activated lymphocytes, on the surface of tumor and
endothelial cells, or in angiogenic endothelial cells within the
tumor vasculature [6,13,31,52]. The expression of nucleolin
mRNA has been systematically detectable in peripheral blood
lymphocytes of healthy individuals, and in vitro stimulation of cells
leads to an enhanced expression of nucleolin mRNA and surface
nucleolin [31,53,54]. Here we demonstrate that enhanced expres-
sion of surface nucleolin in tumor cells is due to its induction that is
highly associated to the state of cell proliferation. Indeed, nucleolin
mRNA induction is reduced markedly in normal fibroblasts that
reach confluence, while it occurs continuously even in post-
confluent epithelial tumor cells consistent with their capacity to
proliferate without contact inhibition. When cell metabolism is
slowed down at reduced temperature in epithelial tumor cells, then
nucleolin mRNA induction is reduced markedly but it is resumed
rapidly once cells are returned back to 37uC. In endothelial cells
(HUVECs), we show that the enhanced expression of nucleolin
mRNA is associated with the induction of surface nucleolin in
response to activation of cells, such as in response to VEGF.
Accordingly, expression of nucleolin on the surface of HUVECs is
markedly reduced in cultures incubated with actinomycin D for
few hours. Previously by laser scanning confocal immunofluores-
cence microscopy we have demonstrated that the expression of
surface nucleolin is enhanced strongly in activated cells, while it is
reduced markedly in growth-arrested cells and in cells cultured
with actinomycin D or cycloheximide. Interestingly, such modifi-
cations in the expression of surface nucleolin occur in the absence
of any apparent effect on the level and nuclear localization of
nuclear nucleolin [6], thus illustrating once again that expression
of surface nucleolin occurs continuously compared to its nuclear
counterpart.
Treatment of cells with the nucleolin antagonist HB-19 pseudo-
peptide results in a selective reduction of surface/cytoplasmic
nucleolin without any apparent effect on the level or nucleolar
localization of nuclear nucleolin [13]. In such HB-19 treated cells,
nucleolin mRNA is continuously induced but it is not translated.
The molecular mechanism of such a specific translational block on
nucleolin mRNA in the absence of nucleolin protein remains to be
investigated. However, it is tempting to speculate that nucleolin
mRNA might require the nucleolin protein for its translation as it
is the case for metalloproteinase-9 (MMP-9) and bcl2 oncogene
mRNA [4,55,56]. Indeed, nucleolin present in the cytoplasm binds
39-untranslated region in the mRNA of MMP-9 and Bcl-2, a
process that is necessary for the stability and translational
efficiency of these mRNAs [4,5]. Nucleolin-binding to MMP-9
mRNA increases the production of the enzyme that by degrading
extracellular matrix components promotes tumor metastasis,
whereas in B-cell chronic lymphocytic leukemia cells the increased
levels of cytoplasmic nucleolin is directly related to overexpression
of the bcl2 oncogene that blocks apoptosis.
Surface nucleolin serves as a low affinity receptor for HIV-1 and
various growth factors, such as midkine, pleiotrophin, and
lactoferrin [7,10,17,18,19]. Binding of these ligands results in
clustering of cell-surface nucleolin in lipid raft membrane
microdomains before endocytosis of the ligand-nucleolin complex
by an active process. Accordingly, surface nucleolin could shuttle
ligands between the cell surface and the nucleus thus act as a
mediator for the extracellular regulation of nuclear events
[18,20,21]. Here we show that ligand internalization is increased
in the presence of elevated calcium concentrations in the culture
medium, whereas chelation of calcium inhibits internalization,
thus indicating that extracellular calcium plays a key role in the
mechanism of surface nucleolin mediated active internalization of
Figure 5. Induction of nucleolin mRNA in human umbilical vein endothelial cells (HUVECs). A. Nucleolin mRNA levels were monitored by
RT-PCR in HUVECs cultured in the EBM-2 medium containing 2% FBS in the absence (lane 1) or presence of 5 mg/ml actinomycin D for 6 hours (lane
2). Serum starved cells for 24 hours (lane 3) were stimulated for 6 hours by suspending in the EBM-2/2% FBS medium (lane 4) or in fresh starvation
medium containing 100 ng/ml VEGF in the absence (lane 5) or presence of actinomycin D (lane 6). The size of RT-PCR product for nucleolin and
GAPDH was 835 and 983 bp, respectively. B. The nucleolin PCR-bands were quantified by using the NIH image software. The histograms represent
the intensity of the PCR products in respect to the control sample that was considered 100%. C. Reduced expression of surface nucleolin in HUVECs in
response to inhibition of RNA transcription. HUVECs cultured on glass slides were treated or not with actinomycin D (5 mg/ml) for 6 hours. Cells were
then washed in PBS, incubated (45 min, 20uC) with anti-nucleolin mAb D3 to result clustering of surface nucleolin, fixed with PFA, and processed for
laser confocal immunofluorescence microscopy [6]. The scans of cells toward the middle cell layer are presented with the respective phase contrasts.
doi:10.1371/journal.pone.0015787.g005
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nalization of specific ligands, we recently reported that ligand
binding to surface nucleolin could also induce calcium entry into
cells, a process inhibited by chelating calcium from the culture
medium [15]. It might therefore be possible that ligand triggered
calcium entry is necessary for the rearrangement of actin
cytoskeleton that affect the actions of contractile proteins, as well
as being a cofactor for the activation of a number of intracellular
signaling pathways [57]. As Nucleolin is shown to bind Ca
2+
[58,59], and is involved in epidermal Ca
2+ homeostasis [60], it
remains to be shown whether binding of calcium to surface
nucleolin is a necessary step for ligand internalization via surface
nucleolin. In view of this, its implication in different metabolic
events, its capacity to bind various pathogens and diverse range of
Figure 6. The constant induction of nucleolin mRNA is
associated with the proliferative capacity of tumor cells. A.
Nucleolin mRNA is induced constantly in post-confluent epithelial
tumor cells compared to normal fibroblasts. The 3T3 cells considered as
normal fibroblasts and carcinoma MDA-MB-231, MDA-MB-435 and
LNCaP cells were passaged at 2.5610
5 cells/25 cm
3 flasks and extracted
at different days as indicated. Day 2, 3, and 6 represent subconfluent,
confluent, and post-confluent cells, respectively. B. Reduction of
nucleolin mRNA in epithelial tumor cells with decreased cellular
metabolism. Subconfluent MDA-MB-231 and MDA-MB-435 cells were
incubated either at 37uCo r2 0 uC for 2 and 4 hours before RNA
extraction. Nucleolin mRNA expression was carried out by Q-PCR using
GAPDH RNA as endogenous control mRNA. For comparative purposes,
the level of nucleolin mRNA expression of the first sample in each set of
experiment was considered 100% (the clear histograms). The percent
decrease in nucleolin mRNA expression is given at day 2 and 3 for the
3T3 compared to day 1 in section A, and at day 4 at 20uC compared to
day 4 at 37uC in section B.
doi:10.1371/journal.pone.0015787.g006
Figure 7. Rapid induction of nucleolin mRNA in response to
cold and heat shock stress. A. Selective enhancement of nucleolin
and Hsp70 mRNA expression after cold shock. Lanes 0, 1, and 2
represent RT-PCR products before, and 1 or 2 hours after cold shock at
4uC, respectively. B. Selective induction of nucleolin and Hsp70 mRNA
expression after cold shock. Cells were stressed by cold shock at 20 or
4uC in the absence (lanes -) or presence (lanes +) of actinomycin D
(5 mg/ml), and total RNA was prepared after 1 hour. C. Selective
induction of nucleolin and Hsp70 mRNA expression after heat shock.
Cells were stressed by heat shock at 44uC in the absence (lanes -) or
presence (lanes +) of actinomycin D (5 mg/ml), and total RNA was
prepared after 1 and 2 hours (sections1H, 2H). D/E. Relative nucleolin
and Hsp70 mRNA levels after cold and heat shock. Cells in the presence
or absence of actinomycin D were stressed by cold shock at 20uCo r4 uC,
and by heat shock at 44uC, and total RNA was extracted before
(histogram C), immediately following cold or heat shock (histograms
0 hour), and 1 or 2 hours after the shock as indicated. In these
experiments, MDA-MB-435 cells were processed for the cold and the
heat shock treatments at two days after passage (Materials and
methods). Total RNA from various samples were assayed for nucleolin
(NCL), neucleophosmin (NPM), Hsp70, CIRP, RBM3 and GAPDH RNA
expression by RT-PCR (in A, B, and C); the size of RT-PCR products are
835, 320, 320, 252, 396 and 983 bp, respectively. Expression of nucleolin
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gest that surface nucleolin functions as scavenger receptors
[3,51,61,62]. Interestingly, surface nucleolin expression and ligand
internalization via surface nucleolin has often been associated with
the expression of the low-density lipoprotein receptor-related
protein-1, a multifunctional scavenger receptor that mediates the
uptake of various ligands from the pericellular environment
[7,12,20,63].
In addition to its association with tumor cell proliferation, here
we show that cold or heat shock stress affect the expression of
nucleolin mRNA. This is due to a specific induction but not
stabilization of nucleolin mRNA, since it is prevented by
actinomycin D in the absence of an apparent effect on the
expression of the mRNA of another nucleolar protein, nucleo-
phosmin. Interestingly, enhanced expression of nucleolin mRNA
after a cold or heat shock occurs concomitantly with the enhanced
expression of Hsp70 mRNA. On the other hand, no apparent
effect is observed on the expression of the two major cold-shock
induced proteins CIRP and RBM3, which like nucleolin contain
RNA binding motifs and a C-terminal glycine rich domain, and
are up-regulated in human tumors [3,49]. The simultaneous
induction of nucleolin and Hsp70 mRNA has also been shown to
occur during early stage of liver regeneration [64,65], thus
suggesting that enhanced expression of nucleolin and Hsp70 is
not just fortuitous to cold and heat shock treatment of cells in vitro,
but it may occur in vivo in response to physiologically relevant stress
and proliferation events.
Previously, nuclear nucleolin and nucleophosmin were reported
to be part of the cellular response to genotoxic stress, and several
stress-responsive transcripts that are potentially regulated by
nucleolin have been identified [66]. In response to DNA damage
conditions or heat shock, a significant fraction of nucleolar
nucleolin was shown to form a complex with the replication
protein A, an essential factor in many DNA processing reactions
[67,68]. Intracellular nucleolin has also been reported to be a
crucial downstream effector of Hsp70 in the protection of
cardiomyocytes against oxidative stress-induced apoptosis [69].
Hsp70 family of stress proteins are ubiquitous and highly con-
served proteins whose expression is induced in response to a wide
variety of physiological and environmental insults, such as heat
shock, oxidative stress, anticancer drugs [70], and cold shock as
shown here. Hsp70 has a dual function depending on its intra-
cellular or extracellular location [70]. Intracellular Hsp70 with
other heat shock proteins play an essential role as molecular
chaperones by assisting the correct folding of nascent and stress-
accumulated misfolded proteins, whereas extracellular Hsp70 is
thought to be internalized via scavenger receptors to promote cell
survival by stabilizing the membranes of lysosomes [71,72,73]. In
view of this latter and the concomitant induction of Hsp70 and
surface nucleolin under stress conditions, the potential implication
of surface nucleolin in the antiapoptotic effect of Hsp70 remains to
be determined.
Several reports have now provided evidence that surface nucleo-
lin is a promising target for cancer therapy [13,37,40,74,75].
Figure 8. Calcium dependent internalization of HB-19 that binds the RGG domain of surface nucleolin. HeLa cells were passaged in
DMEM culture medium. Two days later fresh DMEM (in A and C) or RPMI (in B and D) culture medium was added to the cell monolayer in the absence
or presence of 5 mM EGTA (B) or CaCl2 (D) as indicated. Internalization of HB-19/Btn (5 mM) was then carried out at 37uC for 90 min before fixation
with PFA-Triton and processing for confocal microscopy. Fixed cells were successively incubated with rabbit anti-biotin and goat Texas Red-
conjugated anti-rabbit IgG. A scan corresponding to a cross-section toward the middle of the cell monolayer is shown.
doi:10.1371/journal.pone.0015787.g008
and Hsp70 mRNA was analyzed by Q-PCR (in D and E) using GAPDH
RNA as endogenous control mRNA. The ordinates give the relative
mRNA expression levels compared to the control sample (histograms
C), i.e. before cold or heat shock.
doi:10.1371/journal.pone.0015787.g007
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compared to conventional cancer drugs, since nucleolin is
continuously and abundantly expressed in tumor compared to
normal cells, thus making tumor cells the preferential targets of
inhibitors of surface nucleolin. Another parameter that could
contribute to the lack of toxicity is the capacity of an inhibitor to
block the functioning of surface nucleolin without affecting nuclear
nucleolin, which controls many aspects of gene expression [1,3]. In
this respect, HB-19 treatment is not toxic in vitro and in vivo
[13,37,52]. After specifically binding to surface nucleolin, HB-19
enterscellsandaccumulatesinthecytoplasmbutitdoesnotcrossthe
nuclear membrane. Consequently, the effect of HB-19 is exerted
differentiallyvia thecellsurface expressednucleolinwithoutaffecting
nuclear nucleolin.
Materials and Methods
Cells and culture medium
Human breast (MDA-MB-231, MDA-MB-435 [13]), prostate
(LNCaP, from American Type Culture Collection, ATCC,
Rockville, MD), and cervical (HeLa [76]) epithelial cancer cells
were grown in DMEM-glutamax medium (Gibco Invitrogen,
Cergy-Pontoise, France) containing GlutaMAX
TM, 4.5 g/l glu-
cose and supplemented with 10% heat-inactivated (56uC for
30 min) fetal bovine serum (FBS; Hyclone, Thermo Fisher
Scientific, Inc). G401 nephroblastoma cells (ATCC) were cultured
in McCoy’s (Gibco) containing 2 mM L-glutamine and supple-
mented with 10% heat-inactivated FBS. Jurkat (acute T cell
leukemia [77]), HuT 78 (cutaneous T lymphocytes [78]) and CEM
(acute lymphoblastic leukemia, CEM/clone 13 provided by Luc
Montagnier [78]) were cultured in RPMI-1640 medium (Gibco)
containing GlutaMAX
TM, and supplemented with 10% heat-
inactivated FBS. Cells were kept at logarithmic growth phase and
used at a cell density of 2-5610
5/ml. 3T3 cells (mouse embryonic
fibroblast, ATCC) were cultured in DMEM medium without
pyruvate containing 4.5 g/l glucose and 10% bovine calf serum
(BCS, Gibco). Human umbilical vein endothelial cells (HUVECs)
were provided by Jose ´ Courty (from Clonetics; Biowhittaker,
Emerain-ville, France) and cultured between passages 2 and 5 in
EBM-2 Bullekit medium (Biowhittaker) supplemented with 2%
bovine calf serum (BCS). All cultures were grown at 37uCi na
humidified atmosphere under 5% CO2.
Peptide constructs
The HB-19 pseudopeptide 5[Ky(CH2N)PR-TASP, for [Lysy
(CH2N)Pro-Arg]-template-assembled synthetic peptide, binds
specifically surface nucleolin and block its function. The template
in HB-19, presents pentavalently the tripeptide 5[Ky(CH2N)PR
where (CH2N) represents a reduced peptide bond between lysine
and proline residues. The synthesis of HB-19 and biotinylated HB-
19 (HB-19/Btn; this is used for the recovery of surface nucleolin)
were synthesized by Jean Paul Briand as described previously
using solid phase peptide methodology [16,79]. All peptides were
obtained at a high purity (95%), and their integrity was controlled
by matrix-associated laser desorption ionization-time-of-flight
analysis. The synthetic fluorescein isothiocyanate (FITC)-coupled
Tat (amino acid residues 48–60) with the sequence of FITC-Ahx-
YGRKKRRQRRRPPQS-OH was provided by Jean Paul Briand,
IBMC, Strasbourg.
Preparation of cytoplasmic and nuclear extracts
Cells washed in phosphate-buffered saline (PBS) were lysed in
buffer E (20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 5 mM
MgCl2,5 m Mb-mercaptoethanol, protease inhibitor cocktail
(Sigma) and 0.5% Triton X-100) and the nuclei were pelleted by
centrifugation (1000 g for 5 min). For the preparation of nuclear
extracts, the nuclear pellet was disrupted in buffer I (20 mM Tris-
HCl, pH 7.6, 50 mM KCl, 400 mM NaCl, 1 mM EDTA, 5 mM
b-mercaptoethanol, protease inhibitor cocktail, 1% Triton X-100,
and 20% glycerol). The nucleus-free supernatants and the nuclear
Figure 9. Calcium dependent internalization of surface nucleolin. DMEM-cultured HeLa cells were incubated at 37uC with mAb D3 (15 mg/
ml) in the absence (A, D) or presence of additional 3 mM CaCl2 (B, E) or 5 mM EGTA (C, F). After 3 hours, cells were further incubated at room
temperature for 90 min before PFA (7%) or PFA-Triton (7%-0.5%) fixation. The anti-nucleolin antibody mAb D3 was revealed by FITC-labeled goat
anti-mouse antibodies. A scan corresponding to a cross-section toward the middle of the cell monolayer is shown.
doi:10.1371/journal.pone.0015787.g009
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supernatants were stored at 220uC. Aliquots of crude cell extracts
were diluted in 2 fold concentrated electrophoresis sample buffer
containing SDS, heated and analyzed by SDS-polyacrylamide gel
electrophoresis (PAGE) [9,10].
Analysis of the cell-surface-expressed nucleolin
Two days after seeding, subconfluent cells (about 5610
6 cells/
75 cm
2 flask) were incubated (45 min, 20uC) with 5 mM of HB-
19/Btn. After washing extensively in PBS containing 1 mM
EDTA (PBS-EDTA), nucleus-free cell extracts were prepared
in lysis buffer E. The complex formed between cell-surface
expressed nucleolin and HB-19/Btn was isolated by purifica-
tion of the extracts using NeutrAvidin agarose (100 ml; Pierce
Biotechnology) in PBS-EDTA. After 3 hours at 6uC, the avidin-
agarose samples were washed extensively with PBS-EDTA. The
purified surface nucleolin was eluted in the electrophoresis sample
buffer containing SDS and analyzed by 10% SDS–polyacryl-
amide gel electrophoresis (PAGE). The presence of nucleolin
was then revealed by immunoblotting using mAb D3 against
nucleolin as described before [10,16]. The presence of actin was
monitored with mAb anti-actin A-4700 from Sigma. To estimate
the half-life of the nucleolin protein, the intensity of nucleolin
protein bands (100 kDa) was quantified by using the NIH image
software. To monitor the profile of proteins in crude cells
extracts, gels were stained with Brilliant Blue G-Colloidal Con-
centrate from Sigma.
Laser scanning confocal immunofluorescence
microscopy
Cells were plated 24 hours before the experiment in eight-well
glass slides (Lab-Tek Brand; Nalge Nunc International, Naperville,
IL). Cells were fixed with either paraformaldehyde (3.7% PFA,
10 min) for membrane staining to monitor the clustered surface
nucleolin or PFA/Triton X-100 (10 min 3.7% PFA, 3 washing
with PBS, and permeabilization using 0.5% Triton solution) for
staining intracellular HB-19/Btn or nucleolar nucleolin [6]. For
labeling of surface nucleolin, cells were incubated with mAb D3
for 45 min at room temperature before PFA fixation and
processing for confocal immunofluorescence microscopy. Incuba-
tion at room temperature prevents intracellular translocation of
antibody-nucleolin complex and allows antibody-dependent clus-
tering of surface nucleolin [6]. The secondary antibodies were the
following: FITC-conjugated goat anti-mouse IgG (Sigma), Rabbit
anti-biotin concentrate (IgG fraction; Enzo Diagnostics, Inc., New
York), Texas Red dye-conjugated goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories).
Cold and heat shock treatment of MDA-MB-435 and
HeLa cells
For the cold shock treatment, subconfluent cells in 25 cm
3 flasks
were cooled by transfer to a refrigerator at 4uC for 10–15 min,
during which time the temperature of the culture medium
becomes reduced gradually to 24, 16 and 12uC after 5, 10, and
15 min, respectively. Cells were then left at room temperature
(20–22uC) for 1–6 hours as indicated in individual experiments
before extraction of total RNA. For the heat shock treatment, cells
were heated for 15 min by immersion of the flasks in a water bath
at 44uC. Cells were then left at room temperature for the indicated
times before RNA extraction. In order to monitor the net
induction of nucleolin mRNA after cold and heat shock, the
recovery of cells was carried out at room temperature, since at
37uC there is constant induction of nucleolin mRNA.
Nucleolin mRNA expression monitored by reverse
transcription-polymerase chain reaction (RT-PCR)
Adherent cells (NIH 3T3, MDA-MB-231, MDA-MB-435,
G401, HeLa, LNCaP) were passaged in Dulbecco’s Modified
Eagle Medium (DMEM) culture medium containing 10% FCS in
6-well plates. After 2 days, subconfluent cells were stimulated by
replacing the culture medium by DMEM containing 10% FCS.
Such stimulated cells in the absence or presence of actinomycin D
(5 mg/ml), cycloheximide (50 mg/ml), or tunicamycin (10 mg/ml)
were cultured for 3–5 hours before extraction for total RNA using
RNeasy Mini Kit (Qiagen) according to the manufacturer’s
instructions. Leukemia cells (HuT 78, Jurkat, CEM) passaged in
RPMI culture medium containing 10% FCS were suspended at
5610
5 cells/ml in the absence or presence of inhibitors for 4–5 h
before preparation of RNA extracts. RT was carried out with
oligo(dT) and 2–4 mg of total RNA using Superscript II Reverse
Transcriptase (Invitrogen). PCR was performed in a RoboCycler
96 (Stratagene, La Jolla, CA, USA) with specific primers for
human nucleolin (59-TTGAATTCATCATGGTGAAGCTCGC-
GAAGGC-39 and 59-TAGGGCCCAGGCTCTTCCTCCTC-39),
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (59-TGA-
AGG-TCGGAGTCAACGGATTTGGT-39 and 59-CATGTG-
GGCCATGAGGTCCA-CCAC-39), nucleophosmin (59- TGGT-
TCTCTTCCCAAAGTGG-39 and 59-TAAAACCAAGCAAAG-
GGTGG-39), cold shock protein CIRP (59-GGGTCGTTGT-
GGTGCGCTGT-39 and 59- TGGCATCCTTAGCGTCGT-
CA-39), cold shock protein RBM3 (59- CGCAGCCCCGTCC-
CTGTTTT-39 and 59-GTAGCTGCGACCACGCCCAT-39),
and heat shock protein Hsp70 (59-AAGGTGGAGATCATCG-
CCAA-39 and 59-GCGATCTCCTTCATCTTGGT-39). PCR
amplification conditions were: 95uC for 2 min, 30 cycles of
95uC for 30 sec, 60uC for 30 sec and 72uC for 45 sec, and 72uC
for 5 min. The intensity of nucleolin bands was quantified by using
the NIH image software.
Real Time quantitative PCR (Q-PCR)
Q-PCR amplification was performed in a 7900HT fast real-
time PCR System (Applied Biosystems, Foster City, CA) using 384
well plates. For each reaction, each individual sample was run in
triplicate wells with 5 ml of ABSOLUTE
TM QPCR SYBR
Absolute QPCR Green Rox Mix (Thermo Scientific), 0.2 mlo f
10 mM forward and reverse primer (giving a final concentration of
200 nM), 1 ml of cDNA at 40 or 80-fold dilution, and 3.6 mlo f
water. Non-template controls were run in triplicate for each
primer master mix. Q-PCR amplification parameters were the
following: an initial denaturation at 95uC for 10 min, followed by
40 cycles with denaturation at 95uC for 5 s, and the annealing/
elongation at 60uC for 30 s, followed a dissociation stage at 95uC
15 s, 60uC 15 s and 95uC 15 s. The expression of nucleolin (NCL)
mRNA was investigated with primers specific for Human (Hu) and
murine (Mu) nucleolin in human and mouse cells respectively. For
endogenous control RNA expression, we used oligonucleotide
primers specific for 28S ribosomal RNA (rRNA) and for human
and murine GAPDH. The primer sequences were designed using
the primer blast site at NCBI. The following primers were used:
Hu NCL (59-AGGAGGAGGAAGAAGAGGAG-39 and 59-A -
CAAAGAGATTGAAAGCCGTAG-39; product size 148 bp); Hu
GAPDH (59-GCACCGTCAAGGCTGAGAA-39 and 59-AGG-
GATCTCGCTCCTGGAA-39; product size 75 bp); Mu NCL (59-
AAGCAGCACCTGGAAAACG-39 and 59-TCTGAGCCTTC-
TACTTTCTGTTTCTTG-39; product size 85 bp); Mu GAPDH
(59-GAACATCATCCCTGCATCCA-39 and 59-CCAGTGAGC-
TTCCCGTTCA-39; product size 78 bp); rRNA 28S (59- GTA-
AAACTAACCTGTCTCACG-39 and 59- AAGCAGGAGGT-
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CACCACCCCCAGCTA-39 and 59- TCGCCGAACTTGCGG-
CCAAT-39; product size 137 bp). The relative mRNA expression
was calculated using the comparative C(T) method also referred to
as the 2 (-DeltaDeltaC(T)) method [80]. 28S ribosomal RNA or
GAPDH RNA were used as endogenous controls for RNA
expression. Q-PCR results are expressed in relative levels or as
percentage of their respective controls (means 6 SD).
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